MyFinsight
Home
Blog
About
Contact
ino: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$3,398,534
Accounts receivable from
affiliated entity
$978,590
Short-term investments
$14,235,770
Cash and cash
equivalents
$36,567,420
Other assets
$2,012,476
Operating lease
right-of-use assets
$6,956,780
Investments in affiliated
entity
$2,495,730
Fixed assets, net
$2,740,356
Total current assets
$55,180,314
Total assets
$69,385,656
Accumulated other
comprehensive loss
-$647,356
Accumulated deficit
-$1,818,930,043
Total liabilities and
stockholders equity
$69,385,656
Total inovio
pharmaceuticals, inc....
-$7,719,977
Additional paid-in capital
$1,811,803,850
Common stock
$53,572
Total liabilities
$77,105,633
Operating lease
liability, net of current...
$7,281,737
Total current
liabilities
$69,823,896
Grant funding
liability from affiliated...
$42,152
Operating lease liability
$2,738,490
Common stock warrant
liabilities
$50,384,043
Accrued clinical trial
expenses
$955,970
Accounts payable and
accrued...
$379,721
Accounts payable and
accrued...
$15,323,520
Back
Back
Balance Sheet
source: myfinsight.com
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)